A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
Phase of Trial: Phase III
Latest Information Update: 25 May 2017
At a glance
- Drugs Memantine (Primary)
- Indications Brain metastases; Cognition disorders
- Focus Therapeutic Use
- 19 May 2017 Planned primary completion date changed from 1 Nov 2020 to 1 Sep 2018.
- 25 Aug 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 19 Feb 2015 New trial record